CRVO CervoMed Inc.

NASDAQ

$1.45

CervoMed Inc. (CRVO) Earnings News

Earnings press releases, previews and reviews for CervoMed Inc. (CRVO), newest first.

Monday September 28, 2026 7:30 AM ET

CervoMed Announces Pharmacokinetic Results with New Neflamapimod Oral Tablet Formulation and Secures FDA Removal of Drug Exposure Limit

Monday August 10, 2026 7:30 AM ET

CervoMed Reports Second Quarter 2026 Financial Results and Provides Corporate Updates

Wednesday June 10, 2026 7:30 AM ET

CervoMed Announces Private Placement Financing and Plan to Focus on Strategic Partnering to Advance Neflamapimod into Phase 3 for Dementia with Lewy Bodies

Monday May 18, 2026 7:30 AM ET

CervoMed Reports First Quarter 2026 Financial Results and Provides Corporate Updates